BlackRock Institutional Trust’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
MC
OIM
BFA
BA
ACH
BlackRock Institutional Trust's PACB Position: Q4 2016 in Review
BlackRock Institutional Trust increased its Pacific Biosciences (PACB) stake by 7.5% in Q4 2016, buying an estimated $1.02M and bringing the position to 2,013,325 shares worth $7.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2554.
BlackRock Institutional Trust first reported a position in PACB in Q2 2013 and has held it in 15 quarters since. The position peaked at $19M in Q4 2015. 115 funds tracked by Wall St. Rank hold PACB as of Q4 2016.
- BlackRock Institutional Trust held 2,013,325 shares of Pacific Biosciences worth $7.65M as of Q4 2016.
- BlackRock Institutional Trust bought 140,100 Pacific Biosciences shares in Q4 2016, an estimated $1.02M.
- Pacific Biosciences made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2554 holding.
- BlackRock Institutional Trust first reported a position in Pacific Biosciences in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's Pacific Biosciences position peaked at $19M in Q4 2015.
- 115 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.